Cyclodextrin complexed generic drugs are generally not bio-equivalent with the reference products: Therefore the increase in number of marketed drug/cyclodextrin formulations is so slow

Journal of Inclusion Phenomena

Volumn 52, Issue 1, 2005, Pages 1-11

  Szejtli, József ^a  

^a CycloLab Cyclodextrin Research & Development Laboratory Ltd   (Hungary)

Author keywords

Advantages of complexation; Approval status of CDs; Bioavailability; Cyclodextrin; Drug; Supergeneric drugs

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; 8 CHLOROTHEOPHYLLINE; ALBENDAZOLE; ALFADEX; ALLIDEX; AMIODARONE; ARTEMISIN; BENEXATE; BETA CYCLODEXTRIN; BETA CYCLODEXTRIN SULFOBUTYL ETHER; CARBAMAZEPINE; CARMOFUR; CEFDITOREN PIVOXIL; CEFOTIAM; CEFOTIAM HEXETIL; CEPHALOSPORIN; CETIRIZIN; CETIRIZINE; CHLORAMPHENICOL; CHLORDIAZEPOXIDE; CHLOTAZOL; CISAPRIDE; CLOMIPRAMINE; CLOROCIL; COORDINAX PREPULSID; CYCLODEXTRIN; DANAZOL; DEFLAZACORT; DEXAMETHASONE; DEXTROMETHORPHAN; DEXTROMORAMIDE; DICLOFENAC; DIGOXIN; DIPHENHYDRAMINE; ESTRADIOL; FENTIAZAC; FLUOXETINE; FLURBIPROFEN; FUROSEMIDE; GAMMA CYCLODEXTRIN; GARLESSENCE; GARLIC EXTRACT; GARLIC OIL; GENERIC DRUG; GLIBENCLAMIDE; GLYCERYL TRINITRATE; GLYMESASON; HYDROCORTISONE; IBUPROFEN; IODINE; IPRIFLAVONE; ITRACONAZOLE; KETOCONAZOLE; LIMAPROST; LIXAZINONE; LONIDAMINE; MENA GARGLE; MENAQUINONE; MITOEXTRA; MITOMYCIN; MITOMYCIN C; NICOGUM; NICOTINE; NICOTINE GUM; NIMEDEX; NIMESULIDE; NITRENDIPINE; NITROPEN; OMEBETA; OMEPRAZOLE; OPLAMON; PHENYTOIN; PIROXICAM; PIROXICAM BETA CYCLODEXTRIN; PRASTERONE; PREDNISOLONE; PROSTAGLANDIN E1; PROSTAGLANDIN E2; PROSTAVASIN; RENIN INHIBITOR; RUTOSIDE; RYNATHISOL; SPIRONOLACTONE; STADA TRAVEL; TEBOROXIME TC 99M; TEGRA; TIAPROFENIC ACID; TOLBUTAMIDE; TRANSILLIUM; VORICONAZOLE; ZIPRASIDONE;

AREA UNDER THE CURVE; BIOEQUIVALENCE; COMPLEX FORMATION; DRUG ABSORPTION; DRUG ACTIVITY; DRUG APPROVAL; DRUG BIOAVAILABILITY; DRUG COST; DRUG EXCRETION; DRUG FORMULATION; DRUG MARKETING; DRUG SOLUBILITY; DRUG STABILITY; DRUG TOLERABILITY; ENCAPSULATION; HUMAN; HYDROPHILICITY; LIPOPHILICITY; NONHUMAN; PATENT; PH MEASUREMENT; REVIEW; SHELF LIFE;

EID: 21244492028     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10847-004-7161-z     Document Type: Review

References (52)

1. CD-News (a monthly abstracting newsletter since 1986, dedicated exclusively to CD literature, production, marketing, related conferences, etc.), edited and published by Cyclolab Ltd., Budapest.
2. J. Szejtli 1994 Med. Res. Rev. 14 353
3. D.O. Thompson 1997 Crit. Rev. Therapeutic Drug Carrier Sys. 14 1 1
4. K.H. Frömming J. Szejtli 1993 Cyclodextrins in Pharmacy Kluwer Academic Dordrecht
5. J. Szejtli 1988 Cyclodextrin Technology Kluwer Academic Dordrecht 450
6. CD-News: Approval status of CDs in 2003/2004, 18(1-3), 2004
7. A. Gerlóczy J. Szemán K. Csabai L. Kolbe L. Jicsinszky G.D. Acerbi P. Ventura E. Redenti J. Szejtli 1996 Proc. 8th Int CD Symp. (Budapest) Kluwer Acad Publ. Dordrecht 515 518
8. S. Hirai, T. Makino, and H. Koyama: Eur. Pat. Appl. 1985, EP 163433 4 Dec 1985.
9. Y. Horiuchi M. Kikuchi F. Hirayama K. Uekama M. Ueno T. Ijitsu 1988 J. Pharm. Soc. Jpn. 108 11 1093
10. M. Tateno I. Sugiyama O. Ebi 1988 Chemotherapy 36 Suppl. 6 180
11. F. Levai, I. Szatmari, Z. Vargay: In Proc. Int. Symp. Cyclodextrins, 4th, pp. 343-347.O. Huber, and J. Szejtli. Kluwer: Dordrecht, Neth., 1988PI.
12. H. Seo K. Uekama 1989 J. Pharm. Soc. Jpn. 109 10 778
13. H. Kurihara and A. Hashimoto: Jpn. Kokai Tokkyo Koho, 1989 JP 01287094 17 Nov 1989.
14. C.D. Yu S.A. Sweetana N.I. Chu G.J.L. Lee I.J. Massey 1989 Drug Dev. Ind. Pharm. 15 609
15. K. Dietzel K.S. Estes M.E. Brewster N.S. Bodor H. Derendorf 1989 Pharm Res. 6 9 S131
16. E.E.Z. El-Din A.S. Tantawy 1990 J Drug Res. 19 1-2 45
17. K. Dietzel K.S. Estes M.E. Brewster N.S. Bodor H. Derendorf 1990 Int. J. Pharm. 59 3 225
18. N.T. Yusuff, P. York, H. Chrystyn, R.D. Swallow, P.N. Bramly, and M.S. Losowsky: British Pharmaceutical Conf., 127th Meeting, Cardiff, 10-13 Sept., 1990.
19. A.Z. Abosehmah P. York P.N. Bramley R. Burgul V. Wong R.D. Swallow 1992 Pharm. Res. 9 10 S306 Suppl.
20. A.M. Kaukonen H. Lennernas J.P. Mannermaa 1998 J. Pharm. Pharmacol. 50 6 611
21. Y. Horiuchi F. Hirayama K. Uekama 1991 J. Pharm. Soc. Jpn. 111 10 592 99
22. S. Choudhury K.F. Nelson 1991 Pharm. Res. 8 10 S136
23. S. Choudhury and K.F. Nelson. In A.R. Hedges (ed.), Minutes Int. Symp. Cyclodextrins, 6th Publisher: Ed. Sante, Paris, 1992, pp. 452-455.
24. S. Choudhury K.F. Nelson 1992 In. J. Pharm. 85 1-3 175
25. G.P. Palmieri F. Cantalamessa P. Di Martino C. Nasuti S. Martelli 2002 Drug. Dev. Ind. Pharmacy 28 1241
26. K. Uekama M. Otogiri Y. Uemara T. Fujinaga K. Arimari N. Matsuo K. Tasaki A. Sugii 1983 Pharmacobio-Dyn. 6 124
27. G.-F. Xu, T.-S. Shi, and G.-W. Shen: The Sixth International Cyclodextrin Symposium, Chicago, April 21-24, 1992.
28. B.G. Woodcock S. Rietbrock P.G. Merz 1993 Br J Clin Pharmacol. 35 5 546P
29. D. Acerbi E. Lebacq I. Rondelli A. Stockis P. Venture 1990 Drug Invest. 2 Suppl. 4 50
30. H. Yamaguchi, M. Hattori, R. Ibuki, H. Yoshida, Y. Shimazaki, A. Kawamura, T. Takahashi, N. Ohnishi, and T. Hata: PCT Int. Appl. 1994, WO 9425062 941110.
31. K. Miyake, T. Horikawa, M. Yamamoto, F. Hirayama, K. Uekama, H. Sumiyoshi, and H. Noda: 7th Int. Symp. on Cyclodextrins, Tokyo, 25-28 April, pp. 435-438, 1994.
32. J.H. Kim J.I. Kim K.T. Lee S.J. Kim H.K. Seo S.H. Seo 1996 Yakche Hakhoechi 26 3 169
33. S.I.F. Badawy M.M. Ghorab C.M. Adeyeye 1996 Int. J. Pharm. 128 1-2 45
34. I. Kolbe, A. Gerloczy, J. Szeman, M. Vikmon, J. Szejtli, P. Ventura, E. Redenti, G. Amari, and D. Acerbi: Conference on Pharmaceutical Application of Cyclodextrins, Lawrence, Kansas, USA, June 29-July 2, 1997.
35. A. Gerloczy, M. Vikmon, J. Szeman, J. Szejtli, E. Redenti, and D. Acerbi: Conference on Pharmaceutical Application of Cyclodextrins, Lawrence, Kansas, USA, June 29-July 2, 1997.
36. F. Veiga and F. Teixeira: Conference on Pharmaceutical Application of Cyclodextrins, Lawrence, Kansas, USA, June 29-July 2, 1997.
37. F. Veiga C. Fernandes F. Teixeira 2000 Int. J. Pharm. 202 1-2 165
38. D.M. Rekkas, C.A. Kagkadis, P.P. Dallas, and C. Reppas: Conference on Pharmaceutical Application of Cyclodextrins, Lawrence, Kansas, USA, June 29-July 2, 1997.
39. J. Savolainen K. Jarvinen L. Matilainen T. Jarvinen 1998 Int. J. Pharm. 165 1 69
40. B. Evrard, G. Piel, T. Van Hees, F. Ghalmi, B. Losson, and L. Delattre: 2nd World Meeting on Pharmaceutics Biopharmaceutics Pharmaceutical Technology, Paris 25-28 May, 1998.
41. A.M. Kaukonen, H. Lennernas, and J.-P. Mannermaa: In J.J.T. Labandeira and J.L. Vila-Jato (eds.), Proc. Int. Symp. Cyclodextrins, 9th (Meeting Date, 1998). Kluwer Academic Publishers, Dordrecht, Neth., 1999, pp. 227-230.
42. Y. Ono, M. Takahashi, and N. Koide: Jpn. Kokai Tokkyo Koho, JP 11199518, 19990727; JP 1997-369142 19971226; 1999.
43. S.D. Yoo B.M. Yoon H.S. Lee K.C. Lee 1999 J. Pharm. Sci. 88 11 1119
44. J. Geczy J. Bruhwyler J. Scuvee-Moreau V. Seutin H. Masset J.C. Van Heugen A. Dresse C. Lejeune E. Decamp L. Szente J. Szejtli J.-F. Liegeois 2000 Psychopharmacology (Berlin) 151 4 328
45. J.W. Wong K.H. Yuen 2001 Int. J. Pharmaceutics 227 1-2 177
46. N. Ozdemir S. Ordu Y. Ozkan 2000 Drug Dev. Ind. Pharm. 26 8 857
47. G. Piel, I. Delneuville, and L. Delattre: In: J. Szejtli and L. Szente, (eds.), Proc. Int. Synt. Cyclodextrins 8th Kuwer Academic Publishers 1996, pp. 487-490.
48. Y. Chul-Soon, R. Yong-Dal, C. Han-Gou, and Y. Pong-Kyu: AAPS Meeting Abstract, 2003.
49. C.F. Palmer: PCT Int. Appl. WO9104026 Apr 4, 1991.
50. P.C. Mora M. Cirri B. Allolio F. Carli P. Mura 2003 J. Pharm. Sci. 91 2177
51. J. Szejtli, M. Vikmon, L. Szente, and A. Gerlóczy: in press.
52. D. French 1957 Adv. Carbohydrate Chem. 12 233